Tumor-endogenous PD-1 promotes cell proliferation and predicts poor survival in non-small cell lung cancer

por Gan, Fanyi, Zhang, Chuanfen, Xia, Liang, Deng, Senyi
Publicado 2022

Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer

por Bai, Yuquan, Zhou, Lu, Zhang, Chuanfen, Guo, Minzhang, Xia, Liang, Tang, Zhenying, Liu, Yi, Deng, Senyi
Publicado 2023

Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance

por Zhang, Chuanfen, Wang, Chunmei, Yang, Zhenyu, Bai, Yuquan, Shukuya, Takehito, Poh, Mau-Ern, Ekman, Simon, Li, Jian, Xu, Yuyang, Deng, Senyi
Publicado 2022

Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer

por Bai, Yuquan, Li, Chuan, Xia, Liang, Gan, Fanyi, Zeng, Zhen, Zhang, Chuanfen, Deng, Yulan, Xu, Yuyang, Liu, Chengwu, Deng, Senyi, Liu, Lunxu
Publicado 2022

Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway

por Cheng, Jiahan, Xia, Liang, Hao, Xiaohu, Gan, Fanyi, Bai, Yuquan, Zhang, Chuanfen, Mao, Yonghong, Zhu, Yunke, Pu, Qiang, Park, Dong Won, Tavolari, Simona, Mei, Jiandong, Chen, Yaohui, Deng, Senyi, Liu, Lunxu
Publicado 2022